Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2026)
Caribou Biosciences' (CRBU) quarterly Amortizatization of Intangibles came in at $269000.0 in Q1 2026, down 40.49% year-on-year from $452000.0 in Q1 2025, and up 68.12% on a QoQ basis from $160000.0 in Q4 2025.
Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 6 years of Amortizatization of Intangibles data on file, last reported at $269000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 40.49% year-over-year to $269000.0 in Q1 2026; TTM through Mar 2026 was $957000.0, a 73.7% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 75.88% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $269000.0, up from $160000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for CRBU reached as high as $2.4 million in Q3 2023 and fell as low as -$1.6 million in Q4 2023.
- Historically, Amortizatization of Intangibles has averaged $668058.8 across 5 years, with a median of $452000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles soared 1836.54% in 2022 and plunged 279.07% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $903000.0 in 2022, then plunged by 279.07% to -$1.6 million in 2023, then soared by 162.96% to $1.0 million in 2024, then sank by 84.28% to $160000.0 in 2025, then jumped by 68.12% to $269000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $269000.0 in Q1 2026, $160000.0 in Q4 2025, and $235000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Caribou Biosciences | 152.90 Mn | 35.27 Mn | - | 269,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 269,000.00 |
| Mar 31, 2026 | 269,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 946,000.00 |
| Jun 30, 2024 | 946,000.00 |
| Mar 31, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Dec 31, 2023 | -1.62 Mn |